Andronesi, Ovidiu C.
Arrillaga-Romany, Isabel C.
Ly, K. Ina
Bogner, Wolfgang
Ratai, Eva M.
Reitz, Kara
Iafrate, A. John
Dietrich, Jorg
Gerstner, Elizabeth R.
Chi, Andrew S.
Rosen, Bruce R.
Wen, Patrick Y.
Cahill, Daniel P.
Batchelor, Tracy T.
Article History
Received: 8 July 2017
Accepted: 21 March 2018
First Online: 16 April 2018
Competing interests
: T.T.B. received consulting honoraria from Merck & Co., Roche, Kirin Pharmaceuticals, Spectrum, Amgen, and Novartis. The other authors declare no competing interests.